Aprea Therapeutics Inc (APRE)
5.59
-0.21
(-3.62%)
USD |
NASDAQ |
May 16, 16:00
5.50
-0.09
(-1.61%)
After-Hours: 20:00
Aprea Therapeutics Enterprise Value: -2.015M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -2.015M |
| May 15, 2024 | -0.8748M |
| May 14, 2024 | -0.3861M |
| May 13, 2024 | -2.015M |
| May 10, 2024 | -2.015M |
| May 09, 2024 | -2.504M |
| May 08, 2024 | -4.486M |
| May 07, 2024 | -4.296M |
| May 06, 2024 | -3.807M |
| May 03, 2024 | -3.318M |
| May 02, 2024 | -2.775M |
| May 01, 2024 | -3.861M |
| April 30, 2024 | -4.676M |
| April 29, 2024 | -4.761M |
| April 26, 2024 | -4.133M |
| April 25, 2024 | -3.318M |
| April 24, 2024 | -4.296M |
| April 23, 2024 | -3.210M |
| April 22, 2024 | -4.567M |
| April 19, 2024 | -3.318M |
| April 18, 2024 | -1.907M |
| April 17, 2024 | -1.255M |
| April 16, 2024 | -0.6033M |
| April 15, 2024 | -0.3318M |
| April 12, 2024 | -1.364M |
| Date | Value |
|---|---|
| April 11, 2024 | -0.3318M |
| April 10, 2024 | 1.297M |
| April 09, 2024 | 0.4252M |
| April 08, 2024 | 1.297M |
| April 05, 2024 | 1.840M |
| April 04, 2024 | 1.134M |
| April 03, 2024 | 3.850M |
| April 02, 2024 | 3.469M |
| April 01, 2024 | 2.112M |
| March 28, 2024 | 14.72M |
| March 27, 2024 | 11.35M |
| March 26, 2024 | 10.54M |
| March 25, 2024 | 11.39M |
| March 22, 2024 | 11.59M |
| March 21, 2024 | 12.84M |
| March 20, 2024 | 13.65M |
| March 19, 2024 | 14.95M |
| March 18, 2024 | 13.92M |
| March 15, 2024 | 11.97M |
| March 14, 2024 | 7.197M |
| March 13, 2024 | 8.499M |
| March 12, 2024 | 1.411M |
| March 11, 2024 | 3.691M |
| March 08, 2024 | 5.036M |
| March 07, 2024 | 6.232M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-33.92M
Minimum
May 18 2022
987.30M
Maximum
Dec 27 2019
142.25M
Average
7.197M
Median
Mar 14 2024
Enterprise Value Benchmarks
| NeuBase Therapeutics Inc | -11.16M |
| Stoke Therapeutics Inc | 552.66M |
| NovaBay Pharmaceuticals Inc | 5.209M |
| Palatin Technologies Inc | 23.43M |
| iBio Inc | 16.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.810M |
| Total Expenses (Quarterly) | 3.150M |
| EPS Diluted (Quarterly) | -0.67 |
| Earnings Yield | -59.39% |